Wolverine Trading, LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $360,774 - $498,031	-1,700 Reduced 14.78%	9,800 $2.08 Million
Q2 2024 Aug 14, 2024	SELL	$193.33 - $291.99 $5.37 Million - $8.12 Million	-27,800 Reduced 70.74%	11,500 $3.22 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $2.28 Million - $3.77 Million	13,300 Added 51.15%	39,300 $10.5 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $1.28 Million - $2.51 Million	10,600 Added 68.83%	26,000 $6.02 Million
Q3 2023 Nov 15, 2023	SELL	$146.04 - $225.78 $233,664 - $361,248	-1,600 Reduced 9.41%	15,400 $2.25 Million
Q2 2023 Aug 23, 2023	BUY	$203.88 - $312.0 $632,028 - $967,200	3,100 Added 22.3%	17,000 $3.93 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $3.21 Million - $4.27 Million	13,900 New	13,900 $3.26 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $599,643 - $787,149	9,900 Added 215.22%	14,500 $912,000
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $29,020 - $50,100	-500 Reduced 9.8%	4,600 $331,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $441,531 - $804,931	-7,900 Reduced 60.77%	5,100 $507,000
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $108,510 - $142,635	1,500 Added 13.04%	13,000 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$78.35 - $105.02 $517,109 - $693,132	6,600 Added 134.69%	11,500 $920,000
Q2 2021 Aug 06, 2021	SELL	$97.2 - $137.59 $291,600 - $412,770	-3,000 Reduced 37.97%	4,900 $476,000
Q1 2021 May 14, 2021	SELL	$108.54 - $125.2 $249,642 - $287,960	-2,300 Reduced 22.55%	7,900 $920,000
Q4 2020 Feb 12, 2021	SELL	$110.06 - $133.7 $1.03 Million - $1.26 Million	-9,400 Reduced 47.96%	10,200 $1.13 Million
Q3 2020 Nov 13, 2020	BUY	$99.78 - $124.21 $628,614 - $782,523	6,300 Added 47.37%	19,600 $2.34 Million
Q2 2020 Aug 13, 2020	BUY	$60.13 - $125.71 $601,300 - $1.26 Million	10,000 Added 303.03%	13,300 $1.37 Million
Q1 2020 May 11, 2020	BUY	$66.76 - $93.49 $220,308 - $308,517	3,300 New	3,300 $231,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$773 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$637 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$633 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$622 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$616 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account